Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18750990 | DEVICES AND SYSTEMS FOR ABLATION THERAPY | June 2024 | November 2025 | Abandon | 16 | 2 | 0 | No | No |
| 18046472 | DEVICES, SYSTEMS, AND METHODS OF APPLYING NANO-DIMENSIONED ICE PARTICLES TO ANIMAL TISSUES | October 2022 | September 2025 | Abandon | 44 | 1 | 0 | No | No |
| 17949735 | INTRAVITAL COOLING DEVICE | September 2022 | September 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17911981 | BODY ELECTRODE FOR RECORDING ELECTRO-PHYSIOLOGICAL SIGNALS | September 2022 | July 2025 | Abandon | 34 | 1 | 0 | No | No |
| 17840699 | CATHETER DEVICE AND CATHETER | June 2022 | March 2026 | Abandon | 45 | 2 | 0 | No | No |
| 17707119 | CONDUCTIVE PAD | March 2022 | July 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17636882 | DISPOSABLE SPIRAL ELECTRODE FOR FETAL SCALP | February 2022 | July 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17636231 | COLD AND HOT COMPRESS SYSTEM | February 2022 | April 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17634350 | Multi-Terminal Sensors for Thread-Based Circuitry | February 2022 | September 2025 | Abandon | 44 | 1 | 0 | No | No |
| 17629059 | WEARABLE BIOPOTENTIAL PATCH WITH METHOD TO OPTIMIZE COMFORT AND ACCURACY | January 2022 | November 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17624364 | DEVICES, SYSTEMS AND METHODS FOR ASSISTANCE OF BALLOON ABLATION | January 2022 | August 2025 | Abandon | 44 | 2 | 0 | No | No |
| 17520239 | HEATED SLEEVE FOR A PROSTHETIC LIMB | November 2021 | February 2026 | Abandon | 52 | 3 | 0 | No | No |
| 17494432 | SURGICAL METHODS FOR CONTROL OF ONE VISUALIZATION WITH ANOTHER | October 2021 | March 2026 | Abandon | 53 | 3 | 0 | Yes | No |
| 17492659 | ELECTROCHEMICAL THERAPY OF CANCEROUS TUMORS BASED ON INTRA-THERAPEUTICAL IMPEDANCE MONITORING | October 2021 | November 2024 | Abandon | 38 | 1 | 0 | No | No |
| 17492654 | ELECTROCHEMICAL THERAPY OF CANCEROUS TUMORS BASED ON INTRA-THERAPEUTICAL IMPEDANCE MONITORING | October 2021 | November 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17460438 | SYSTEM AND METHODS FOR INSERTION DEPTH TRACKING | August 2021 | August 2025 | Abandon | 48 | 4 | 0 | No | No |
| 17398185 | Wearable Tags | August 2021 | April 2025 | Abandon | 44 | 2 | 0 | Yes | No |
| 17418068 | DETACHABLE SURGICAL INSTRUMENT | June 2021 | October 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17287708 | PLASMA TREATMENT DEVICE | April 2021 | December 2024 | Abandon | 44 | 1 | 0 | No | No |
| 17237146 | METHOD OF PERFORMING CRYONEUROLYSIS | April 2021 | April 2025 | Abandon | 48 | 2 | 0 | Yes | No |
| 17286843 | ELECTRODE AND USES THEREOF | April 2021 | September 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17217905 | DEVICES AND SYSTEMS FOR ABLATION THERAPY | March 2021 | March 2024 | Allow | 35 | 0 | 0 | No | No |
| 17208252 | METHOD FOR TREATMENT OF ERECTILE DYSFUNCTION | March 2021 | May 2024 | Allow | 38 | 1 | 0 | No | No |
| 17204348 | MEDICAL DEVICE, CONTROL METHOD, AND COMPUTER-READABLE STORAGE MEDIUM | March 2021 | January 2025 | Allow | 46 | 2 | 0 | Yes | No |
| 17173230 | ELECTROPHYSIOLOGY CATHETER DESIGN | February 2021 | June 2024 | Allow | 40 | 1 | 0 | No | No |
| 16952186 | Vein Heating Assembly | November 2020 | April 2025 | Abandon | 53 | 2 | 0 | No | No |
| 17064513 | BIOCOMPATIBLE IMPLANTABLE ELECTRODE | October 2020 | November 2024 | Abandon | 49 | 1 | 0 | No | No |
| 17019984 | BEVELED END EFFECTOR ASSEMBLY | September 2020 | November 2025 | Abandon | 60 | 6 | 1 | Yes | No |
| 16990981 | TERAHERTZ HEALTHY ROSARY STRUCTURE | August 2020 | September 2024 | Abandon | 49 | 2 | 0 | No | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner BROWN, KYLE MARTZ works in Art Unit 3794 and has examined 18 patent applications in our dataset. With an allowance rate of 22.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.
Examiner BROWN, KYLE MARTZ's allowance rate of 22.2% places them in the 3% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by BROWN, KYLE MARTZ receive 1.89 office actions before reaching final disposition. This places the examiner in the 45% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by BROWN, KYLE MARTZ is 46 months. This places the examiner in the 11% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a -3.1% benefit to allowance rate for applications examined by BROWN, KYLE MARTZ. This interview benefit is in the 7% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 0.0% of applications are subsequently allowed. This success rate is in the 1% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 14.3% of cases where such amendments are filed. This entry rate is in the 15% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants file petitions regarding this examiner's actions, 100.0% are granted (fully or in part). This grant rate is in the 93% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.